Making use of N-of-1 trials to treat ADHD in people with psychosis: a hypothetical case.
作者信息
Dalton Kathryn, Joober Ridha, Karama Sherif, Palaniyappan Lena
机构信息
From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que., Canada (Dalton, Joober, Karama, Palaniyappan); and Robarts Research Institute and Department of Medical Biophysics, Western University, London, Ont., Canada (Palaniyappan).
出版信息
J Psychiatry Neurosci. 2024 Apr 3;49(2):E133-E134. doi: 10.1503/jpn.240010. Print 2024 Jan-Feb.
Abstract
摘要
相似文献
1
Making use of N-of-1 trials to treat ADHD in people with psychosis: a hypothetical case.利用单病例试验治疗精神病患者的注意力缺陷多动障碍：一个假设案例。
J Psychiatry Neurosci. 2024 Apr 3;49(2):E133-E134. doi: 10.1503/jpn.240010. Print 2024 Jan-Feb.
2
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍（ADHD）的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
3
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
4
Risk of hospitalisation for first-onset psychosis or mania within a year of ADHD medication initiation in adults with ADHD.多动症成年患者开始使用多动症药物治疗后一年内首次发作精神病或躁狂症的住院风险。
BMJ Ment Health. 2025 Apr 12;28(1):e301521. doi: 10.1136/bmjment-2024-301521.
5
Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍（ADHD）的药物治疗。
Cochrane Database Syst Rev. 2011 Apr 13(4):CD007990. doi: 10.1002/14651858.CD007990.pub2.
6
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
7
[Impaired time perception in attention deficit hyperactivity disorder].[注意缺陷多动障碍中的时间知觉受损]
Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(6):55-61. doi: 10.17116/jnevro202512506155.
8
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍（ADHD）。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
9
A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.安非他酮用于儿童和青少年注意力缺陷/多动障碍的系统评价
J Child Adolesc Psychopharmacol. 2017 Mar;27(2):112-116. doi: 10.1089/cap.2016.0124. Epub 2016 Nov 4.
10
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的多不饱和脂肪酸（PUFA）
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2.
本文引用的文献
1
Treatment with psychostimulants and atomoxetine in people with psychotic disorders: reassessing the risk of clinical deterioration in a real-world setting.在精神病患者中使用精神兴奋剂和托莫西汀治疗：在真实环境中重新评估临床恶化的风险。
Br J Psychiatry. 2024 Mar;224(3):98-105. doi: 10.1192/bjp.2023.149.
2
Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance.运动障碍与利培酮和哌甲酯的使用：病例报告综述及世界卫生组织药物警戒数据库分析
Eur Child Adolesc Psychiatry. 2021 Jul;30(7):1047-1058. doi: 10.1007/s00787-020-01589-2. Epub 2020 Jul 3.
3
Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study.哌甲酯与青少年及青年精神病风险：一项基于人群的队列研究
Lancet Psychiatry. 2019 Aug;6(8):651-658. doi: 10.1016/S2215-0366(19)30189-0. Epub 2019 Jun 17.
4
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.注意缺陷多动障碍患者使用哌醋甲酯或苯丙胺后出现精神病。
N Engl J Med. 2019 Mar 21;380(12):1128-1138. doi: 10.1056/NEJMoa1813751.
5
[N-of-1 trials in child and adolescent psychiatry: a closer look at stimulants].[儿童和青少年精神病学中的单病例试验：深入研究兴奋剂]
Tijdschr Psychiatr. 2018;60(5):315-325.
6
The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5.世界卫生组织成人注意缺陷多动障碍自我报告筛查量表（适用于《精神疾病诊断与统计手册》第5版）
JAMA Psychiatry. 2017 May 1;74(5):520-527. doi: 10.1001/jamapsychiatry.2017.0298.
7
PANSS-6: a brief rating scale for the measurement of severity in schizophrenia.PANSS-6：一种用于测量精神分裂症严重程度的简短评定量表。
Acta Psychiatr Scand. 2016 Jun;133(6):436-44. doi: 10.1111/acps.12526. Epub 2015 Nov 12.
8
Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study.处方兴奋剂的使用与精神病或躁狂症住院治疗：一项基于人群的研究。
J Clin Psychopharmacol. 2015 Dec;35(6):667-71. doi: 10.1097/JCP.0000000000000406.
9
Methylphenidate-risperidone combination in child psychiatry: A retrospective analysis of 44 cases.哌醋甲酯-利培酮联合用药在儿童精神病学中的应用：44例回顾性分析
Ann Pharm Fr. 2014 May;72(3):164-77. doi: 10.1016/j.pharma.2013.12.009. Epub 2014 Jan 30.
10
Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day.儿童和青少年注意缺陷多动障碍感知困难的全球印象：一种新工具的信度和效度，该工具从患者、家长和医生的角度评估一天中感知到的困难。
Child Adolesc Psychiatry Ment Health. 2008 May 28;2(1):10. doi: 10.1186/1753-2000-2-10.
Zotero 插件